Invention Grant
US09345713B2 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
有权
6-（5-羟基-1H-吡唑-1-基）烟酰胺抑制剂
- Patent Title: 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
- Patent Title (中): 6-（5-羟基-1H-吡唑-1-基）烟酰胺抑制剂
-
Application No.: US14693110Application Date: 2015-04-22
-
Publication No.: US09345713B2Publication Date: 2016-05-24
- Inventor: Jason W. Brown , Melinda Davis , Anthony Ivetac , Benjamin Jones , Andre A. Kiryanov , Jon Kuehler , Marion Lanier , Joanne Miura , Sean Murphy , Xiaolun Wang
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Oksaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Oksaka
- Agent Matthew J. Russo; David M. Stemerick
- Main IPC: A61K31/496
- IPC: A61K31/496 ; A61K31/551 ; A61K31/5513 ; C07D401/04 ; C07D401/14 ; C07D405/14 ; C07D413/14 ; C07D491/107 ; C07D417/14 ; C07D471/08 ; C07D487/06 ; C07D487/10 ; C07D491/10 ; A61K31/444 ; A61K31/4545 ; A61K31/4985 ; A61K31/5377
Abstract:
The present invention provides a method of treating acute heart failure by administering a compound of the formula: or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20150224113A1 6-(5-HYDROXY-1H-PYRAZOL-1-YL)NICOTINAMIDE INHIBITORS OF PHD Public/Granted day:2015-08-13
Information query
IPC分类:
